PHAT Dividend History & Analysis | 0% Yield
PHAT has a dividend yield of 0% and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| SIGA | 601 M | 7.99% | 11.0% |
| PFE | 141,343 M | 7.02% | 6.23% |
| GS71 | 82,384 M | 5.01% | 6.50% |
| BMY | 94,037 M | 5.08% | 5.14% |
| SAN | 115,455 M | 4.66% | 5.40% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| RPRX | 21,093 M | 22.9% | 100% |
| ZTS | 69,314 M | 16.7% | 100% |
| LLY | 677,175 M | 11.9% | 99.5% |
| SIGA | 601 M | 10.1% | 98.8% |
| MRK | 212,686 M | 5.69% | 98.5% |
Similar Stocks with Attractive Dividends - Compare PHAT Dividends with its Peer-Group
7.99% Yield
3.89% Yield
4.66% Yield
3.42% Yield
3.07% Yield
2.52% Yield
PHAT Dividend History: as of September 2025
No dividends paid yet.PHAT Dividend FAQ
Phathom Pharmaceuticals (NASDAQ: PHAT) is a U.S.‑based biopharma focused on novel acid‑suppression therapies for gastrointestinal (GI) disorders. Its lead asset, VOICE‑ZNA (vonoprazan), is a potassium‑competitive acid blocker (P‑CAB) that has completed Phase III trials for erosive gastroesophageal reflux disease (GERD) and for Helicobacter pylori eradication (both Triple‑Pak and Dual‑Pak formulations). The company also reports Phase III data for VOICE‑ZNA in non‑erosive GERD and eosinophilic esophagitis (EoE) across adult and adolescent cohorts.
What is the Dividend Yield of PHAT?
As of September 2025, PHAT`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 11.00.Does PHAT pay a dividend?
As of September 2025 PHAT does not pay a dividend.How often does PHAT pay dividends?
Over the last 12 months, PHAT has issued dividend payments.Will PHAT pay dividends in 2025?
The next Ex-Dividend date for Phathom Pharmaceuticals (PHAT) is currently unknown.What is the next Ex-Dividend Date for PHAT?
The next Ex-Dividend date for Phathom Pharmaceuticals (PHAT) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of PHAT?
PHAT's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of PHAT?
PHAT's 5-Year Yield on Cost is -%. If you bought PHAT's shares at 36.70 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of PHAT?
PHAT Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does PHAT have a good Dividend Yield?
PHAT`s 0.00% Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of PHAT?
The Dividend Payout Ratio of PHAT is unknown.What is the Dividend Rating of PHAT?
PHAT`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-09-16 04:12